Kathleen <span>M.</span> Egan, ScD
Researcher

Kathleen M. Egan, ScD

Academic Rank: Senior Member

Overview

Discipline

    • Cancer Epidemiology
    • Neuro-Oncology
    • Cancer Epidemiology Program
    • Cancer Chemoprevention Research Interest Group
    • Melanoma Research Center of Excellence

Education & Training

    • Harvard University, ScD
    • Boston University, MPH
Research

Dr. Egan is an epidemiologist with research interests in molecular epidemiology and lifestyle-directed prevention of cancer.  Over her career, she has published more than 180 primary research reports on breast and ovarian cancer risk factors and outcome, and etiologic and outcomes-focused research in melanoma and primary tumors of the brain. In the area of breast/ovarian cancer, she has published findings from the Nurses’ Health Study cohorts. She was also site PI for the ‘Collaborative Breast Cancer Study’ (CBCS), a multi-institutional, population-based case-control study of breast cancer that ultimately enrolled more than 20,000 breast cancer cases and 20,000 community controls. Ovarian cancer cases were also enrolled in one cycle of funding.  Based on 3 successive cycles of R01 funding, the CBCS is the basis for many original research studies focused on lifestyle risk factors in breast and ovarian cancer.  Dr. Egan also served as PI on a study examining genetic variants in the estrogen pathway based on the CBCS and she remains an active member of the Breast Cancer Association Consortium (BCAC) to which CBCS has made a considerable contribution. The large CBCS case cohort also offers new insights on lifestyle factors associated with breast cancer survival based on follow up of case women enrolled in the CBCS beginning in 1992.  Dr. Egan remains active in studies of breast cancer risk factors, with currently funded research examining the impact of gut microbial composition (the ‘gut microbiome’) on circulating estrogen levels in postmenopausal women based on Moffitt’s long-running ‘Lifetime’ protocol.        Dr. Egan’s key area of active research is the elucidation of risk factors for primary tumors of the brain (glioma and meningioma). Glioma is one of the most devastating human tumors with a largely unknown etiology. Recognizing this knowledge gap, in 2005, Dr. Egan launched a multicenter case-control study to examine genetic and lifestyle risk factors for these tumors. Incident cases are enrolled at a network of high-volume academic medical centers in the Southeastern US. The infrastructure also provides opportunity to enroll patients with meningioma, a ‘benign’ tumor of the CNS, for etiologic research. More than 2000 glioma cases, 500 meningioma cases and 2000 community controls are enrolled in “GliomaSE”. Published and in press findings pinpoint early life (higher birth order; delayed menarche; prolonged growth phase) as a critical period establishing risk of adult glioma and largely exclude major established cancer risk factors (BMI, smoking, alcohol consumption). GliomaSE was also the first study to independently validate genetic risk associations from GWAS both for glioma and meningioma. Dr. Egan is also an active collaborator in the glioma arena, with the study offering valuable opportunities for discovery and validation of risk associations.   Dr. Egan has also been active in etiologic and clinical/ translational research in melanoma. She has published more than 50 research articles on clinical outcomes in and risk factors for melanoma of the uveal tract, a rare and poorly understood tumor of the pigmented layer of the inner eye, based on the large clinic population at the Massachusetts Eye & Ear Infirmary, a major referral center for treatment of these tumors.  Dr. Egan is also active in cutaneous melanoma research at Moffitt and via the BioGenoMEL consortia in Europe and the US.     Finally, Dr. Egan is active in postdoctoral research training at Moffitt and served as Program Leader of Moffitt’s R25T program and is Associate Program Director of a T32 Postdoctoral Training Fellowship in Molecular Epidemiology in the Department of Cancer Epidemiology.

Publications

  • Wagoner KG, Song E, King J, Egan KL, Debinski B, Wolfson M, Spangler J, Sutfin EL. Availability and Placement of Electronic Nicotine Delivery Systems at the Point-of-Sale. Nicotine Tob Res. 2017 Sep. Pubmedid: 29059443.
  • Wagoner KG, Sutfin EL, Song E, King JL, Egan KL, Reboussin B, Debinski B, Spangler J, Wolfson M. Trends in point-of-sale tobacco marketing around college campuses:Opportunities for enhanced tobacco control efforts. J Am Coll Health. 2017 Oct. Pubmedid: 29020532.
  • Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A. Emerging Trends in Family History of Breast Cancer and Associated Risk. Cancer Epidemiol Biomarkers Prev. 2017 Oct. Pubmedid: 28986348.
  • Little RB, Nabors LB, Olson JJ, Thompson ZJ, Rozmeski CM, LaRocca RV, Forsyth PA, Thompson RC, Oster RA, Chowdhary SA, Egan KM. Older age at the completion of linear growth is associated with an increased risk of adult glioma. Cancer Causes Control. 2017 Jul;28(7):709-716. Pubmedid: 28260177. Pmcid: PMC5469709.
  • Little RB, Burt Nabors L, Olson JJ, Thompson ZJ, Rozmeski CM, LaRocca RV, Forsyth PA, Thompson RC, Oster RA, Chowdhary SA, Egan KM. Erratum to: Older age at the completion of linear growth is associated with an increased risk of adult glioma. Cancer Causes Control. 2017 Jul;28(7):717-718. Pubmedid: 28455551.
  • Egan KM, Nabors LB, Thompson ZJ, Rozmeski CM, Anic GA, Olson JJ, LaRocca RV, Chowdhary SA, Forsyth PA, Thompson RC. Analgesic use and the risk of primary adult brain tumor. Eur J Epidemiol. 2016 Sep;31(9):917-925. Pubmedid: 26894804. Pmcid: PMC4991947.
  • Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL, Milne RL, Bolla MK, Wang Q, Dennis J, Agata S, Ahmed S, Aittomäki K, Andrulis IL, Anton-Culver H, Antonenkova NN, Arason A, Arndt V, Arun BK, Arver B, Bacot F, Barrowdale D, Baynes C, Beeghly-Fadiel A, Benitez J, Bermisheva M, Blomqvist C, Blot WJ, Bogdanova NV, Bojesen SE, Bonanni B, Borresen-Dale AL, Brand JS, Brauch H, Brennan P, Brenner H, Broeks A, Brüning T, Burwinkel B, Buys SS, Cai Q, Caldes T, Campbell I, Carpenter J, Chang-Claude J, Choi JY, Claes KB, Clarke C, Cox A, Cross SS, Czene K, Daly MB, de la Hoya M, De Leeneer K, Devilee P, Diez O, Domchek SM, Doody M, Dorfling CM, Dörk T, Dos-Santos-Silva I, Dumont M, Dwek M, Dworniczak B, Egan K, Eilber U, Einbeigi Z, Ejlertsen B, Ellis S, Frost D, Lalloo F, Fasching PA, Figueroa J, Flyger H, Friedlander M, Friedman E, Gambino G, Gao YT, Garber J, García-Closas M, Gehrig A, Damiola F, Lesueur F, Mazoyer S, Stoppa-Lyonnet D, Giles GG, Godwin AK, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Haiman CA, Hallberg E, Hamann U, Hansen TV, Hart S, Hartikainen JM, Hartman M, Hassan N, Healey S, Hogervorst FB, Verhoef S, Hendricks CB, Hillemanns P, Hollestelle A, Hulick PJ, Hunter DJ, Imyanitov EN, Isaacs C, Ito H, Jakubowska A, Janavicius R, Jaworska-Bieniek K, Jensen UB, John EM, Joly Beauparlant C, Jones M, Kabisch M, Kang D, Karlan BY, Kauppila S, Kerin MJ, Khan S, Khusnutdinova E, Knight JA, Konst ...
  • Doepker MP, Thompson ZJ, Harb JN, Messina JL, Puleo CA, Egan KM, Sarnaik AA, Gonzalez RJ, Sondak VK, Zager JS. Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy. J Surg Oncol. 2016 Jan;113(1):98-102. Pubmedid: 26661407. Pmcid: PMC4904728.
  • Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, Baron JA, Willett WC. Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases. J Clin Oncol. 2016 Apr;34(12):1315-1322. Pubmedid: 26811527. Pmcid: PMC4872346.
  • Mulpur BH, Nabors LB, Thompson RC, Olson JJ, LaRocca RV, Thompson Z, Egan KM. Complementary therapy and survival in glioblastoma. Neurooncol Pract. 2015 Sep;2(3):122-126. Pubmedid: 26649185. Pmcid: PMC4671323.
  • Fair AM, Lewis TJ, Sanderson M, Dupont WD, Fletcher S, Egan KM, Disher AC. Increased vitamin D and calcium intake associated with reduced mammographic breast density among premenopausal women. Nutr Res. 2015 Oct;35(10):851-857. Pubmedid: 26321093. Pmcid: PMC4579012.
  • Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty JW, Williams CR, Schreiber F, Parnes HL, Sebti S, Kazi A, Kang L, Quinn GP, Smith T, Yue B, Diaz K, Chornokur G, Crocker T, Schell MJ. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prev Res (Phila). 2015 Oct;8(10):879-887. Pubmedid: 25873370. Pmcid: PMC4596745.
  • Baskin R, Woods NT, Mendoza-Fandiño G, Forsyth P, Egan KM, Monteiro AN. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility. Sci Rep. 2015 Nov;5:17367. Pubmedid: 26610392. Pmcid: PMC4661592.
  • Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I, Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval C, van Limbergen E, Kristensen V, Grenaker Alnæs G, Nord S, Borresen-Dale AL, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV, Antonenkova NN, Dörk T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MW, Khusnutdinova E, Bermisheva M, Prokofyeva D, Takhirova Z, Meindl A, Schmutzler RK, Sutter C, Yang R, Schürmann P, Bremer M, Christiansen H, Park-Simon TW, Hillemanns P, Guénel P, Truong T, Menegaux F, Sanchez M, Radice P, Peterlongo P, Manoukian S, Pensotti V, Hopper JL, Tsimiklis H, Apicella C, South ...
  • Owens MA, Craig BM, Egan KM, Reed DR. Birth desires and intentions of women diagnosed with a meningioma. J Neurosurg. 2015 May;122(5):1151-1156. Pubmedid: 25623387. Pmcid: PMC4524337.
  • Sprague BL, Gangnon RE, Hampton JM, Egan KM, Titus LJ, Kerlikowske K, Remington PL, Newcomb PA, Trentham-Dietz A. Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies. Am J Epidemiol. 2015 Jun;181(12):956-969. Pubmedid: 25944893. Pmcid: PMC4462335.
  • Egan KM, Baskin R, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Monteiro AN. Brain tumor risk according to germ-line variation in the MLLT10 locus. Eur J Hum Genet. 2015 Jan;23(1):132-134. Pubmedid: 24755950. Pmcid: PMC4266750.
  • Schabath MB, Thompson ZJ, Egan KM, Torres BN, Nguyen A, Papenfuss MR, Abrahamsen ME, Giuliano AR. Alcohol consumption and prevalence of human papillomavirus (HPV) infection among US men in the HPV in Men (HIM) study. Sex Transm Infect. 2015 Feb;91(1):61-67. Pubmedid: 25278617. Pmcid: PMC4342055.
  • Davies JR, Jewell R, Affleck P, Anic GM, Randerson-Moor J, Ozola A, Egan KM, Elliott F, García-Casado Z, Hansson J, Harland M, Höiom V, Jian G, Jönsson G, Kumar R, Nagore E, Wendt J, Olsson H, Park JY, Patel P, Pjanova D, Puig S, Schadendorf D, Rachakonda PS, Snowden H, Stratigos AJ, Bafaloukos D, Ogbah Z, Sucker A, Van den Oord JJ, Van Doorn R, Walker C, Okamoto I, Wolter P, Barrett JH, Bishop DT, Newton-Bishop J. Inherited variation in the PARP1 gene and survival from melanoma. Int J Cancer. 2014 Oct;135(7):1625-1633. Pubmedid: 24535833. Pmcid: PMC4106984.
  • Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA. Reproductive windows, genetic loci, and breast cancer risk. Ann Epidemiol. 2014 May;24(5):376-382. Pubmedid: 24792587. Pmcid: PMC4164346.
  • Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA. Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies. Breast Cancer Res Treat. 2014 May;145(1):165-175. Pubmedid: 24647890. Pmcid: PMC4112552.
  • Davies JR, Field S, Randerson-Moor J, Harland M, Kumar R, Anic GM, Nagore E, Hansson J, Höiom V, Jönsson G, Gruis NA, Park JY, Jian G, Rachakonda PS, Wendt J, Pjanova D, Puig S, Schadendorf D, Okamoto I, Olsson H, Affleck P, García-Casado Z, Puig-Butille JA, Stratigos AJ, Kodela E, Donina S, Sucker A, Hosen I, Egan KM, Barrett JH, van Doorn R, Bishop DT, Newton-Bishop J. An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Res. 2014 Mar;27(2):234-243. Pubmedid: 24219834. Pmcid: PMC4065372.
  • Anic GM, Madden MH, Nabors LB, Olson JJ, Larocca RV, Thompson ZJ, Pamnani SJ, Forsyth PA, Thompson RC, Egan KM. Reproductive factors and risk of primary brain tumors in women. J Neurooncol. 2014 Jun;118(2):297-304. Pubmedid: 24700240. Pmcid: PMC4048769.
  • van de Water W, Bastiaannet E, Egan KM, de Craen AJ, Westendorp RG, Balducci L, van de Velde CJ, Liefers GJ, Extermann M. Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care. Geriatr Oncol. 2014 Jul;5(3):252-259. Pubmedid: 24661770. Pmcid: PMC4617765.
  • Madden MH, Anic GM, Thompson RC, Nabors LB, Olson JJ, Browning JE, Monteiro AN, Egan KM. Circadian pathway genes in relation to glioma risk and outcome. Cancer Causes Control. 2014 Jan;25(1):25-32. Pubmedid: 24135790. Pmcid: PMC3947318.
  • Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA. Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan. Cancer Epidemiol. 2014 Feb;38(1):62-65. Pubmedid: 24373701. Pmcid: PMC4023814.
  • Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, Ryken T, Moore MK, Egan KM, Olson JJ. Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol. 2014 Apr;11(4):203-222. Pubmedid: 24569448. Pmcid: PMC4041037.
  • Anic GM, Madden MH, Sincich K, Thompson RC, Nabors LB, Olson JJ, Larocca RV, Browning JE, Pan E, Egan KM. Early life exposures and the risk of adult glioma. Eur J Epidemiol. 2013 Sep;28(9):753-758. Pubmedid: 23681776. Pmcid: PMC3791322.
  • Nichols HB, Trentham-Dietz A, Newcomb PA, Egan KM, Titus LJ, Hampton JM, Visvanathan K. Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer. Breast Cancer Res. 2013 Oct;15(5):R99. Pubmedid: 24152546. Pmcid: PMC3978665.
  • Park JY, Amankwah EK, Anic GM, Lin HY, Walls B, Park H, Krebs K, Madden M, Maddox K, Marzban S, Fang S, Chen W, Lee JE, Wei Q, Amos CI, Messina JL, Sondak VK, Sellers TA, Egan KM. Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):827-834. Pubmedid: 23462921. Pmcid: PMC3708315.
  • Little RB, Madden MH, Thompson RC, Olson JJ, Larocca RV, Pan E, Browning JE, Egan KM, Nabors LB. Anthropometric factors in relation to risk of glioma. Cancer Causes Control. 2013 May;24(5):1025-1031. Pubmedid: 23456313. Pmcid: PMC3633685.
  • Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. Menopause. 2013 Mar;20(3):354-358. Pubmedid: 23435034. Pmcid: PMC3549049.
  • Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, Fasching PA, Hopper JL, Makalic E, Schmidt DF, Southey MC, Beckmann MW, Ekici AB, Fletcher O, Gibson L, Silva Idos S, Peto J, Humphreys MK, Wang J, Cordina-Duverger E, Menegaux F, Nordestgaard BG, Bojesen SE, Lanng C, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Brauch H, Brüning T, Harth V, The Genica Network , Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Kconfab , Group AM, Lambrechts D, Smeets D, Neven P, Paridaens R, Flesch-Janys D, Obi N, Wang-Gohrke S, Couch FJ, Olson JE, Vachon CM, Giles GG, Severi G, Baglietto L, Offit K, John EM, Miron A, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Chanock SJ, Lissowska J, Liu J, Cox A, Cramp H, Connley D, Balasubramanian S, Dunning AM, Shah M, Trentham-Dietz A, Newcomb P, Titus L, Egan K, Cahoon EK, Rajaraman P, Sigurdson AJ, Doody MM, Guénel P, Pharoah PD, Schmidt MK, Hall P, Easton DF, Garcia-Closas M, Milne RL, Chang-Claude J. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 2013 Jun;9(3):e1003284. Pubmedid: 23544014. Pmcid: PMC3609648.
  • Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus LJ, Baron JA, Hampton JM, Passarelli MN, Willett WC. Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol. 2013 Jun;31(16):1939-1946. Pubmedid: 23569314. Pmcid: PMC3661933.
  • Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquita HB, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Cordina-Duverger E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV, Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Alnæs GG, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, García-Closas M, Lissowska J, Sherman ...
  • Anic GM, Madden MH, Thompson RC, Nabors LB, Olson JJ, Larocca RV, Browning JE, Brockman JD, Forsyth PA, Egan KM. Toenail iron, genetic determinants of iron status, and the risk of glioma. Cancer Causes Control. 2013 Dec;24(12):2051-2058. Pubmedid: 23996192. Pmcid: PMC3823695.
  • Siegel EM, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Han G, Egan KM. Prediagnostic body weight and survival in high grade glioma. J Neurooncol. 2013 Aug;114(1):79-84. Pubmedid: 23666204. Pmcid: PMC3729798.
  • Amankwah EK, Thompson RC, Nabors LB, Olson JJ, Browning JE, Madden MH, Egan KM. SWI/SNF gene variants and glioma risk and outcome. Cancer Epidemiol. 2013 Apr;37(2):162-165. Pubmedid: 23276717. Pmcid: PMC3578123.
  • Anic GM, Thompson RC, Burton Nabors L, Olson JJ, Browning JE, Madden MH, Reed Murtagh F, Forsyth PA, Egan KM. An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome. Cancer Causes Control. 2012 Sep;23(9):1443-1449. Pubmedid: 22740028. Pmcid: PMC3563063.
  • Higginbotham KS, Breyer JP, McReynolds KM, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Parl FF, Sanders ME, Page DL, Egan KM, Dupont WD, Smith JR. A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1565-1573. Pubmedid: 22806168. Pmcid: PMC3707501.
  • Egan KM, Wrensch MR, Jenkins RB. Rare and uncommon genetic variants may hold key to the 'missing heritability' in glioma. CNS Oncol. 2012 Nov;1(2):109-112. Pubmedid: 25057857.
  • Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Slaton J, Anderson JK. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemp Clin Trials. 2012 Mar;33(2):279-285. Pubmedid: 22101219. Pmcid: PMC3268882.
  • Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, Prescott J, De Vivo I, Nitti D. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst. 2012 Jun;104(11):840-854. Pubmedid: 22523397. Pmcid: PMC3611810.
  • Xiao Y, Decker PA, Rice T, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Wiemels JL, Tihan T, Prados MD, Chang SM, Berger MS, Kosel ML, Fridley BL, Lachance DH, O'Neill BP, Buckner JC, Thompson RC, Nabors LB, Olson JJ, Brem S, Madden MH, Browning JE, Wiencke JK, Egan KM, Jenkins RB, Wrensch MR. SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res. 2012 Jun;18(11):3154-3162. Pubmedid: 22472174. Pmcid: PMC3607457.
  • Kumar NB, Vadaparampil ST, Mahajan N, Lilienfeld HS, Lee JH, Laronga C, Hakam A, Hein JJ, Egan KM, Arun B, Pal T. Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers. Hereditary Genet. 2012 Jun;1(2). Pubmedid: 26097796. Pmcid: PMC4474476.
  • Egan KM, Nabors LB, Olson JJ, Monteiro AN, Browning JE, Madden MH, Thompson RC. Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet. 2012 Jul;49(7):420-421. Pubmedid: 22706378. Pmcid: PMC3576847.
  • Kumar N, Crocker T, Smith T, Connors S, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Anderson K. Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures. J Clin Trials. 2012 Jan;2(1). Pubmedid: 24533253. Pmcid: PMC3924733.
  • Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, Dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Cordina-Duverger E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV, Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J, Investigators K, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Alnæs GG, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, García-Closas M, Lissowska J, Sherman ME, ...
  • Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Chen YA. Erratum to: Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011 Sep;104(2):543. Pubmedid: 21286782.
  • Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Ann Chen Y. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011 Sep;104(2):535-542. Pubmedid: 21203894. Pmcid: PMC3138895.
  • Newcomb PA, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Warren Andersen S, Greenberg ER, Willett WC. Late age at first full term birth is strongly associated with lobular breast cancer. Cancer. 2011 May;117(9):1946-1956. Pubmedid: 21509772. Pmcid: PMC3117094.
  • Nichols HB, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L, Trentham-Dietz A. Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery?. Am J Epidemiol. 2011 May;173(10):1111-1120. Pubmedid: 21430192. Pmcid: PMC3105288.
  • Higginbotham KS, Breyer JP, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Sanders ME, Page DL, Parl FF, Egan KM, Dupont WD, Smith JR. A multistage association study identifies a breast cancer genetic locus at NCOA7. Cancer Res. 2011 Jun;71(11):3881-3888. Pubmedid: 21610108. Pmcid: PMC3137260.
  • Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN, Holick CN, Titus-Ernstoff L, Egan KM, Holmes MD, Willett WC. Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat. 2011 Jul;128(1):229-236. Pubmedid: 21197569. Pmcid: PMC3201727.
  • Heine JJ, Land WH, Egan KM. Statistical learning techniques applied to epidemiology: a simulated case-control comparison study with logistic regression. BMC Bioinformatics. 2011 Jan;12:37. Pubmedid: 21272346. Pmcid: PMC3045299.
  • Cai Q, Wen W, Qu S, Li G, Egan KM, Chen K, Deming SL, Shen H, Shen CY, Gammon MD, Blot WJ, Matsuo K, Haiman CA, Khoo US, Iwasaki M, Santella RM, Zhang L, Fair AM, Hu Z, Wu PE, Signorello LB, Titus-Ernstoff L, Tajima K, Henderson BE, Chan KY, Kasuga Y, Newcomb PA, Zheng H, Cui Y, Wang F, Shieh YL, Iwata H, Le Marchand L, Chan SY, Shrubsole MJ, Trentham-Dietz A, Tsugane S, Garcia-Closas M, Long J, Li C, Shi J, Huang B, Xiang YB, Gao YT, Lu W, Shu XO, Zheng W. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of Chinese, Japanese, and European ancestry. Cancer Res. 2011 Feb;71(4):1344-1355. Pubmedid: 21303983. Pmcid: PMC3083305.
  • Permuth-Wey J, Thompson RC, Burton Nabors L, Olson JJ, Browning JE, Madden MH, Ann Chen Y, Egan KM. A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J Neurooncol. 2011 Dec;105(3):639-646. Pubmedid: 21744077. Pmcid: PMC3217154.
  • Warren Andersen S, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM, Trentham-Dietz A. Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat. 2011 Dec;130(3):975-980. Pubmedid: 21769659. Pmcid: PMC4306414.
  • Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A, Tollenaar RA, Van't Veer LJ, Fasching PA, Beckmann MW, Ekici AB, Strick R, Peto J, dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Bojesen S, Flyger H, Nordestgaard BG, Benítez J, Milne RL, Ignacio Arias J, Zamora MP, Brenner H, Müller H, Arndt V, Rahman N, Turnbull C, Seal S, Renwick A, Brauch H, Justenhoven C, Brüning T, Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova N, Antonenkova N, Rogov YI, Karstens JH, Bermisheva M, Prokofieva D, Gantcev SH, Khusnutdinova E, Lindblom A, Margolin S, Chenevix-Trench G, Beesley J, Chen X, Mannermaa A, Kosma VM, Soini Y, Kataja V, Lambrechts D, Yesilyurt BT, Chrisiaens MR, Peeters S, Radice P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Mulligan AM, O'Malley FP, Brinton LA, Sherman ME, Lissowska J, Chanock SJ, Hooning M, Martens JW, van den Ouweland AM, Collée JM, Hall P, Czene K, Cox A, Brock IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKa ...
  • Anic GM, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Egan KM. Sleep duration and obesity in a population-based study. Sleep Med. 2010 May;11(5):447-451. Pubmedid: 20363668. Pmcid: PMC2854876.
  • Peterson NB, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Huang Y, Chanock SJ, Haines JL, Egan KM. Association of COMT haplotypes and breast cancer risk in caucasian women. Anticancer Res. 2010 Jan;30(1):217-220. Pubmedid: 20150638. Pmcid: PMC3086748.
  • Lewis TJ, Dupont WD, Egan KM, Jones CD, Disher AC, Riddle WR, Fair AM. The "Got D'ViBE?" study: an inter-institutional project assessing vitamin D and mammographic breast density. J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):17-25. Pubmedid: 20173282. Pmcid: PMC2930256.
  • Fair AM, Wujcik D, Lin JM, Zheng W, Egan KM, Grau AM, Champion VL, Wallston KA. Psychosocial determinants of mammography follow-up after receipt of abnormal mammography results in medically underserved women. J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):71-94. Pubmedid: 20173286. Pmcid: PMC2927817.
  • Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Ceballos RM, Titus-Ernstoff L, Egan KM, Holmes MD. Social networks and survival after breast cancer diagnosis. J Cancer Surviv. 2010 Dec;4(4):372-380. Pubmedid: 20652435. Pmcid: PMC2978785.
  • Kim IK, Lane AM, Egan KM, Munzenrider J, Gragoudas ES. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology. 2010 Aug;117(8):1617-1622. Pubmedid: 20363507.
  • Lane AM, Egan KM, Kim IK, Gragoudas ES. Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol. 2010 Aug;128(8):996-1000. Pubmedid: 20696999.
  • Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Familial Cancer. 2009 Sep;8(2):109-117. Pubmedid: 18763055.
  • Wise LA, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Trichopoulos D, Hampton JM, Egan KM. Exposure to breast milk in infancy and risk of breast cancer. Cancer Causes Control. 2009 Sep;20(7):1083-1090. Pubmedid: 19330531. Pmcid: PMC3152199.
  • Lane AM, Egan KM, Harmon D, Holbrook A, Munzenrider JE, Gragoudas ES. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology. 2009 Nov;116(11):2206-2212. Pubmedid: 19744725.
  • Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kämpjärvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I, Schürmann P, Dörk T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch H, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen SE, Nordestgaard BG, Flyger HL, Peto J, Fletcher O, Johnson N, Dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Van't Veer LJ, Southey MC, Hopper JL, Apicella C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MP, Tollenaar RA, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A, Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PD, Easton DF, Garcia-Closas M. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5) ...
  • Parl FF, Egan KM, Li C, Crooke PS. Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction. Cancer Inform. 2009 May;7:109-121. Pubmedid: 19718449. Pmcid: PMC2730178.
  • Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1403-1409. Pubmedid: 19366908. Pmcid: PMC2715918.
  • Newcomb PA, Nichols HB, Beasley JM, Egan K, Titus-Ernstoff L, Hampton JM, Trentham-Dietz A. No difference between red wine or white wine consumption and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):1007-1010. Pubmedid: 19273487. Pmcid: PMC2710299.
  • Mignone LI, Giovannucci E, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Willett WC, Egan KM. Dietary carotenoids and the risk of invasive breast cancer. Int J Cancer. 2009 Jun;124(12):2929-2937. Pubmedid: 19330841. Pmcid: PMC3564658.
  • Fair AM, Wujcik D, Lin JM, Grau A, Wilson V, Champion V, Zheng W, Egan KM. Obesity, gynecological factors, and abnormal mammography follow-up in minority and medically underserved women. J Womens Health (Larchmt). 2009 Jul;18(7):1033-1039. Pubmedid: 19558307. Pmcid: PMC2851132.
  • Egan KM. Vitamin D and melanoma. Ann Epidemiol. 2009 Jul;19(7):455-461. Pubmedid: 19282200.
  • Kumar N, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Anic G, Egan KM. Tea consumption and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):341-345. Pubmedid: 19124518. Pmcid: PMC3156033.
  • Mignone LI, Giovannucci E, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Orav EJ, Willett WC, Egan KM. Meat consumption, heterocyclic amines, NAT2, and the risk of breast cancer. Nutr Cancer. 2009 Jan;61(1):36-46. Pubmedid: 19116874. Pmcid: PMC4902008.
  • Ahern TP, Lash TL, Egan KM, Baron JA. Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes Control. 2009 Dec;20(10):1837-1844. Pubmedid: 19533391.
  • Huang Y, Trentham-Dietz A, García-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM. Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1321-1323. Pubmedid: 19293312. Pmcid: PMC2692636.
  • Peterson NB, Huang Y, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Anic G, Egan KM. Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3284-3287. Pubmedid: 18990773. Pmcid: PMC2674789.
  • Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Brit J Cancer. 2008 Jun;98(11):1781-1783. Pubmedid: 18506182. Pmcid: PMC2410126.
  • Egan K, Signorello L, Munro H, Hargreaves M, Hollis B, Blot W. Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control. 2008 Jun;19(5):527-535. Pubmedid: 18219582.
  • Fair AM, Wujcik D, Lin JM, Egan KM, Grau AM, Zheng W. Timing is everything: methodologic issues locating and recruiting medically underserved women for abnormal mammography follow-up research. Contemp Clin Trials. 2008 Jul;29(4):537-546. Pubmedid: 18289943. Pmcid: PMC2483696.
  • Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM. Statin use and risk of breast cancer. Cancer. 2008 Jan;112(1):27-33. Pubmedid: 18008366.
  • Holick C, Newcomb P, Trentham-Dietz A, Titus-Ernstoff L, Bersch A, Stampfer M, Baron J, Egan K, Willett W. Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):379-386. Pubmedid: 18250341.
  • Cai H, Shu XO, Egan KM, Cai Q, Long JR, Gao YT, Zheng W. Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women. Pharmacogenet Genomics. 2008 Aug;18(8):657-664. Pubmedid: 18622258. Pmcid: PMC2613759.
  • Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA. Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol. 2008 Aug;168(4):404-411. Pubmedid: 18552361. Pmcid: PMC2727276.
  • Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control. 2008 Aug;19(6):605-613. Pubmedid: 18264784. Pmcid: PMC2729759.
  • Newcomb PA, Egan KM, Trentham-Dietz A, Titus-Ernstoff L, Baron JA, Hampton JM, Stampfer MJ, Willett WC. Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):864-871. Pubmedid: 18381475. Pmcid: PMC2780320.
  • Trentham-Dietz A, Nichols H, Egan K, Titus-Ernstoff L, Hampton J, NewcombPA. Cigarette Smoking and Risk of Breast Carcinoma In Situ. Epidemiology. 2007 Sep;18(5):629-638. Pubmedid: 17700252.
  • Nichols H, Trentham-Dietz A, Egan K, Titus-Ernstoff L, Hampton J, NewcombPA. Oral contraceptive use and risk of breast carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2262-2268. Pubmedid: 18006914.
  • Gaudet M, Egan K, Lissowska J, Newcomb P, Brinton L, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet. 2007 May;121(3-4):483-490. Pubmedid: 17216494.
  • McElroy J, Egan K, Titus-Ernstoff L, Anderson H, Trentham-Dietz A, Hampton J, Newcomb P. Occupational exposure to electromagnetic field and breast cancer risk in a large, population-based, case-control study in the United States. J Occup Environ Med. 2007 Mar;49(3):266-274. Pubmedid: 17351512.
  • Sprague B, Trentham-Dietz A, Newcomb P, Titus-Ernstoff L, Hampton J, Egan K. Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):236-243. Pubmedid: 17301255.
  • Sprague B, Trentham-Dietz A, Garcia-Closas M, Newcomb P, Titus-Ernstoff L, Hampton J, Chanock S, Haines J, Egan K. Genetic variation in TP53 and risk of breast cancer in a population-based case-control study. Carcinogenesis. 2007 Aug;28(8):1680-6. Pubmedid: 17449902.
  • Liang X, Trentham-Dietz A, Titus-Ernstoff L, Newcomb P, Welch R, HutchinsonAA, Hampton J, Sutcliffe C, Haines J, Egan K. Whole-genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1610-1614. Pubmedid: 17684135.
  • Yasui Y, Newcomb P, Trentham-Dietz A, Egan K. Familial relative risk estimates for use in epidemiologic analyses. Am J Epidemiol. 2006 Oct;164(7):697-705. Pubmedid: 16923773.
  • Peterson N, Trentham-Dietz A, Newcomb P, Chen Z, Hampton J, Willett W, Egan K. Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer. 2006 Nov;119(10):2423-2427. Pubmedid: 16921486.
  • Nichols H, Trentham-Dietz A, Hampton J, Titus-Ernstoff L, Egan K, WillettWC, Newcomb P. From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol. 2006 Nov;164(10):1003-1011. Pubmedid: 16928728.
  • Garcia-Closas M, Egan K, Newcomb P, Brinton L, Titus-Ernstoff L, ChanockS, Welch R, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Bardin-Mikolajczak A, Struewing J. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet. 2006 May;119(4):376-388. Pubmedid: 16485136.
  • Peterson N, Trentham-Dietz A, Newcomb P, Chen Z, Gebretsadik T, HamptonJM, Stampfer M, Willett W, Egan K. Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States). Cancer Causes Control. 2006 May;17(4):459-467. Pubmedid: 16596298.
  • Newcomb P, Egan K. Dairy food and ovarian cancer risk. Lancet. 2006 Mar;367(9513):797-799. Pubmedid: 16530561.
  • Marucci L, Lane A, Li W, Egan K, Gragoudas E, Adams J, Collier J, Munzenrider J. Conservation treatment of the eye: Conformal proton reirradiation for recurrentuveal melanoma. Int J Radiat Oncol Biol Phys. 2006 Mar;64(4):1018-22. Epub 2. Pubmedid: 16376492.
  • Zhang Y, Newcomb P, Egan K, Titus-Ernstoff L, Chanock S, Welch R, BrintonLA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):353-358. Pubmedid: 16492928.
  • Long J, Egan K, Dunning L, Shu X, Cai Q, Cai H, Dai Q, Holtzman J, GaoYT, Zheng W. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics. 2006 Apr;16(4):237-243. Pubmedid: 16538170.
  • Egan K. Commentary: sunlight, vitamin D, and the cancer connection revisited. Int J Epidemiol. 2006 Apr;35(2):227-30. Pubmedid: 16303801.
  • Egan KM, Wang M, Fries S, Lucitt MB, Zukas AM, Puré E, Lawson JA, FitzGerald GA. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation. 2005 Jan;111(3):334-342. Pubmedid: 15655126.
  • Egan KM, Sosman JA, Blot WJ. Sunlight and reduced risk of cancer: is the real story vitamin D?. J Natl Cancer Inst. 2005 Feb;97(3):161-163. Pubmedid: 15687354.
  • Egan KM, Newcomb PA, Ambrosone CB, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Kimura MT, Nagase H. STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis. 2004 Nov;25(11):2149-2153. Pubmedid: 15271853.
  • Roscoe L, Egan K, Schonwetter R. Creating an academic-community provider partnership in hospice, palliative care, and end-of-life studies. Cancer Control. 2004 Nov;11(6):397-403. Pubmedid: 15625527.
  • Kang JH, Pasquale LR, Willett WC, Rosner BA, Egan KM, Faberowski N, Hankinson SE. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr. 2004 May;79(5):755-764. Pubmedid: 15113712.
  • Egan KM, Thompson PA, Titus-Ernstoff L, Moore JH, Ambrosone CB. MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett. 2003 Sep;199(1):27-33. Pubmedid: 12963120.
  • Leong NM, Mignone LI, Newcomb PA, Titus-Ernstoff L, Baron JA, Trentham-Dietz A, Stampfer MJ, Willett WC, Egan KM. Early life risk factors in cancer: the relation of birth weight to adult obesity. Int J Cancer. 2003 Mar;103(6):789-791. Pubmedid: 12516100.
  • Fung TT, Spiegelman D, Egan KM, Giovannucci E, Hunter DJ, Willett WC. Vitamin and carotenoid intake and risk of squamous cell carcinoma of the skin. Int J Cancer. 2003 Jan;103(1):110-115. Pubmedid: 12455062.
  • Li W, Gragoudas ES, Egan KM. Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma. Arch Ophthalmol. 2003 Jan;121(1):68-72. Pubmedid: 12523887.
  • Arroyo JG, Postel EA, Stone T, McCuen BW, Egan KM. A matched study of primary scleral buckle placement during repair of posterior segment open globe injuries. Br J Ophthalmol. 2003 Jan;87(1):75-78. Pubmedid: 12488267. Pmcid: PMC1771464.
  • Egan KM, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Mignone LI, Farin F, Hunter DJ. Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States). Cancer Causes Control. 2003 Feb;14(1):43-51. Pubmedid: 12708724.
  • Kang JH, Pasquale LR, Rosner BA, Willett WC, Egan KM, Faberowski N, Hankinson SE. Prospective study of cigarette smoking and the risk of primary open-angle glaucoma. Arch Ophthalmol. 2003 Dec;121(12):1762-1768. Pubmedid: 14662597.
  • Kang JH, Pasquale LR, Willett W, Rosner B, Egan KM, Faberowski N, Hankinson SE. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol. 2003 Aug;158(4):337-346. Pubmedid: 12915499.
  • Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM. Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1503-1504. Pubmedid: 12433736.
  • Bertone ER, Newcomb PA, Willett WC, Stampfer MJ, Egan KM. Recreational physical activity and ovarian cancer in a population-based case-control study. Int J Cancer. 2002 May;99(3):431-436. Pubmedid: 11992414.
  • Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ. Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):593-600. Pubmedid: 12101105.
  • Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002 Dec;120(12):1665-1671. Pubmedid: 12470140.
  • Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002;100:43-48. Pubmedid: 12545676. Pmcid: PMC1358945.
  • McElroy JA, Newcomb PA, Remington PL, Egan KM, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Baron JA, Stampfer MJ, Willett WC. Electric blanket or mattress cover use and breast cancer incidence in women 50-79 years of age. Epidemiology. 2001 Nov;12(6):613-617. Pubmedid: 11679786.
  • García-Closas M, Egan KM, Abruzzo J, Newcomb PA, Titus-Ernstoff L, Franklin T, Bender PK, Beck JC, Le Marchand L, Lum A, Alavanja M, Hayes RB, Rutter J, Buetow K, Brinton LA, Rothman N. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):687-696. Pubmedid: 11401920.
  • Bertone ER, Hankinson SE, Newcomb PA, Rosner B, Willet WC, Stampfer MJ, Egan KM. A population-based case-control study of carotenoid and vitamin A intake and ovarian cancer (United States). Cancer Causes Control. 2001 Jan;12(1):83-90. Pubmedid: 11227928.
  • Gragoudas ES, Lane AM, Regan S, Li W, Judge HE, Munzenrider JE, Seddon JM, Egan KM. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000 Jun;118(6):773-778. Pubmedid: 10865313.
  • Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE, Stampfer M, Willett WC. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control. 2000 Jul;11(6):533-542. Pubmedid: 10880035.
  • Li W, Gragoudas ES, Egan KM. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Arch Ophthalmol. 2000 Aug;118(8):1066-1070. Pubmedid: 10922199.
  • Regan S, Judge HE, Gragoudas ES, Egan KM. Iris color as a prognostic factor in ocular melanoma. Arch Ophthalmol. 1999 Jun;117(6):811-814. Pubmedid: 10369595.
  • Egan KM, Quinn JL, Gragoudas ES. Childbearing history associated with improved survival in choroidal melanoma. Arch Ophthalmol. 1999 Jul;117(7):939-942. Pubmedid: 10408460.
  • Sinilnikova OM, Egan KM, Quinn JL, Boutrand L, Lenoir GM, Stoppa-Lyonnet D, Desjardins L, Levy C, Goldgar D, Gragoudas ES. Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer. 1999 Jul;82(3):325-328. Pubmedid: 10399947.
  • Egan KM, Giovannucci E. Dietary mutagens and the risk of breast cancer. J Natl Cancer Inst. 1998 Nov;90(22):1687-1689. Pubmedid: 9827516.
  • Egan KM, Ryan LM, Gragoudas ES. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates. Arch Ophthalmol. 1998 Mar;116(3):366-370. Pubmedid: 9514491.
  • Egan KM, Newcomb PA, Longnecker MP, Trentham-Dietz A, Baron JA, Trichopoulos D, Stampfer MJ, Willett WC. Jewish religion and risk of breast cancer. Lancet. 1996 Jun;347(9016):1645-1646. Pubmedid: 8642956.
  • Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst. 1996 Jul;88(14):988-993. Pubmedid: 8667430.
  • Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995 Sep;333(10):609-614. Pubmedid: 7637720.
  • Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol. 1995 Feb;119(2):157-164. Pubmedid: 7832221.
  • Young LH, Egan KM, Walsh SM, Gragoudas ES. Familial uveal melanoma. Am J Ophthalmol. 1994 Apr;117(4):516-520. Pubmedid: 8154536.
  • Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol. 1993 May;168(5):1473-1480. Pubmedid: 8498430.
  • Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol. 1992 Aug;110(8):1112-1118. Pubmedid: 1323252.
  • Marcus DM, Mawn LA, Egan KM, Albert DM. Nucleolar organizer regions in iris nevi and melanomas. Am J Ophthalmol. 1992 Aug;114(2):202-207. Pubmedid: 1642296.
  • Gragoudas ES, Egan KM, Arrigg PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol. 1992 Apr;110(4):475-479. Pubmedid: 1562251.
  • Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol. 1990 Sep;108(9):1274-1280. Pubmedid: 2400347.
  • Bitter GA, Egan KM. Expression of interferon-gamma from hybrid yeast GPD promoters containing upstream regulatory sequences from the GAL1-GAL10 intergenic region. Gene. 1988 Sep;69(2):193-207. Pubmedid: 2853097.
  • Ormerod LD, Egan KM. Spontaneous hyphaema and corneal haemorrhage as complications of microbial keratitis. Br J Ophthalmol. 1987 Dec;71(12):933-937. Pubmedid: 3427003. Pmcid: PMC1041348.
  • Seddon JM, Polivogianis L, Gragoudas ES, Hsieh CC, Egan KM. Enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol. 1986 Feb;104(2):175-176. Pubmedid: 3947285.
  • Salmon JR, Kwak J, Acquaviva KD, Egan KA, Brandt K. Validation of the caregiving at life's end questionnaire. Am J Hosp Palliat Care. 22(3):188-194. Pubmedid: 15909781.